Moderate renal insufficiency does not attenuate the clinical benefit of aldosterone antagonists in heart failure

J Am Coll Cardiol. 2012 Nov 13;60(20):2090-1. doi: 10.1016/j.jacc.2012.08.971. Epub 2012 Oct 17.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diuretics / therapeutic use*
  • Female
  • Glomerular Filtration Rate / drug effects*
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Spironolactone / therapeutic use*

Substances

  • Diuretics
  • Spironolactone